What is the role of darbepoetin alfa in the management of anemia in patients with chronic kidney disease?
Explanation
Darbepoetin alfa is a long-acting erythropoiesis-stimulating agent that stimulates erythropoiesis and increases red blood cell production, reducing the need for blood transfusions in patients with anemia related to chronic kidney disease.
Source
Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline











